This special LabCoP session on innovations in SARS-CoV-2 antigen sample collection and testing features Abbott Rapid Diagnostics and Beckman Coulter Inc. It covers:
• High-quality laboratory SARS-CoV-2 antigen testing and its potential to transform the global pandemic response
• The challenges of mass testing of COVID-19 and the benefits of utilising fully automated SARS-CoV-2 antigen tests.
• Panbio™ COVID-19 antigen rapid test device update: nasal swab sampling and testing of asymptomatic populations

Presenters:
• Dr Kuku Appiah Director, Medical & Scientific Affairs, Infectious Diseases Emerging Markets, Abbott Rapid Diagnostics
• Dr Anna Ruzhanskaya, Scientific Marketing Manager, Russia and Eastern Europe, Beckman Coulter Inc.

Please note that ASLM does not endorse these products over others in the global market and the purpose of this session is only to provide a platform for information exchange.

свернуть